Terminated PHASE1 INTERVENTIONAL 4-arm NCT00159510

Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (MB-NO)

A Controlled Prospective Randomized Open-Label Study of Methylene Blue and Inhaled Nitric Oxide in Patients With Septic Shock and Acute Lung Injury

Sponsor: Helse Nord

Conditions Sepsis

Interventions Methylene blue Methylene blue & nitric oxide Nitric oxide

Updated 6 times since 2017 Last updated: Oct 5, 2015 Started: Apr 30, 2004 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Inability to recruit the patients due to the short supply and changed local hospital protocol

Other terminated trials from Helse Nord

Cerebrovascular Accident · Phase PHASE3 · Jun 2013

See all terminations from Helse Nord

Other Sepsis trials with similar outcome

Browse all Sepsis trials

This PHASE1 trial investigates Sepsis and is currently terminated or withdrawn. Helse Nord leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE1
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Helse Nord
Northern State Medical University

Data source: Northern State Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Arkhangelsk, Russia